HLRCC

3 registered clinical trials studyying HLRCC — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes NCT05534854	RenJi Hospital	—
Recruiting	An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Bi NCT04623502	University of Texas Southwestern Medical Center	N/A
Completed	A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Ce NCT01130519	National Cancer Institute (NCI)	Phase 2